{
  "x402Version": 2,
  "id": 38883,
  "slug": "38883",
  "resource": "https://api.magentlab.com/api/calc/who_pv",
  "description": "WHO 2016 polycythemia vera criteria (Arber 2016). Met when all three majors hold, or when major 1 and major 2 hold with subnormal EPO. Major 1 is male Hb >16.5 g/dL or Hct >49%, female Hb >16.0 or Hct >48%, or increased red-cell mass. Major 2 is caller-assigned marrow panmyelosis. Major 3 is JAK2 V617F or exon 12. Not a medical device, not a WHO diagnosis, and not WHO 2022. magent does not assay EPO or sequence JAK2.",
  "type": "http",
  "serviceName": "magent",
  "resourceType": "Agent Service",
  "accepts": [
    {
      "scheme": "exact",
      "network": "eip155:8453",
      "payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
      "asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
      "amount": "5000",
      "amountUsd": 0.005,
      "maxTimeoutSeconds": 600
    }
  ],
  "outputSchema": {
    "properties": {
      "example": {
        "type": "object"
      },
      "type": {
        "type": "string"
      }
    },
    "required": [
      "type"
    ],
    "type": "object"
  },
  "extensions": {
    "bazaar": {
      "info": {
        "iconUrl": "https://api.magentlab.com/favicon.ico",
        "input": {
          "body": {
            "items": [
              {
                "bone_marrow_panmyelosis": false,
                "hematocrit_percent": 45,
                "hemoglobin_g_dl": 15,
                "increased_red_cell_mass": false,
                "jak2_v617f_or_exon12": false,
                "sex": "male",
                "subnormal_epo": false
              },
              {
                "bone_marrow_panmyelosis": false,
                "hematocrit_percent": 45,
                "hemoglobin_g_dl": 15,
                "increased_red_cell_mass": false,
                "jak2_v617f_or_exon12": false,
                "sex": "male",
                "subnormal_epo": false
              }
            ]
          },
          "method": "POST",
          "type": "http"
        },
        "output": {
          "example": {
            "count": 2,
            "items": [
              {
                "bone_marrow_panmyelosis": false,
                "citation": {
                  "authors": "Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW",
                  "doi": "10.1182/blood-2016-03-643544",
                  "id": "arber-2016",
                  "pmid": "27069254",
                  "source": "Blood. 2016;127(20):2391-2405",
                  "title": "The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia"
                },
                "criteria": [
                  {
                    "factor": "major_1",
                    "met": false
                  },
                  {
                    "factor": "major_2",
                    "met": false
                  },
                  {
                    "factor": "major_3",
                    "met": false
                  },
                  {
                    "factor": "minor",
                    "met": false
                  }
                ],
                "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
                "formula": "who_pv",
                "formula_expression": "pv_criteria_met iff (major_1 and major_2 and major_3) or (major_1 and major_2 and minor); major_1 iff increased_red_cell_mass or (male and (hemoglobin_g_dl > 16.5 or hematocrit_percent > 49)) or (female and (hemoglobin_g_dl > 16.0 or hematocrit_percent > 48)); major_2 bone_marrow_panmyelosis; major_3 jak2_v617f_or_exon12; minor subnormal_epo (Arber 2016 WHO 2016 PV). Not WHO 2022",
                "hematocrit_percent": 45,
                "hemoglobin_g_dl": 15,
                "increased_red_cell_mass": false,
                "jak2_v617f_or_exon12": false,
                "major_1": false,
                "major_2": false,
                "major_3": false,
                "minor": false,
                "pv_criteria_met": false,
                "sex": "male",
                "subnormal_epo": false
              },
              {
                "bone_marrow_panmyelosis": false,
                "citation": {
                  "authors": "Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW",
                  "doi": "10.1182/blood-2016-03-643544",
                  "id": "arber-2016",
                  "pmid": "27069254",
                  "source": "Blood. 2016;127(20):2391-2405",
                  "title": "The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia"
                },
                "criteria": [
                  {
                    "factor": "major_1",
                    "met": false
                  },
                  {
                    "factor": "major_2",
                    "met": false
                  },
                  {
                    "factor": "major_3",
                    "met": false
                  },
                  {
                    "factor": "minor",
                    "met": false
                  }
                ],
                "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
                "formula": "who_pv",
                "formula_expression": "pv_criteria_met iff (major_1 and major_2 and major_3) or (major_1 and major_2 and minor); major_1 iff increased_red_cell_mass or (male and (hemoglobin_g_dl > 16.5 or hematocrit_percent > 49)) or (female and (hemoglobin_g_dl > 16.0 or hematocrit_percent > 48)); major_2 bone_marrow_panmyelosis; major_3 jak2_v617f_or_exon12; minor subnormal_epo (Arber 2016 WHO 2016 PV). Not WHO 2022",
                "hematocrit_percent": 45,
                "hemoglobin_g_dl": 15,
                "increased_red_cell_mass": false,
                "jak2_v617f_or_exon12": false,
                "major_1": false,
                "major_2": false,
                "major_3": false,
                "minor": false,
                "pv_criteria_met": false,
                "sex": "male",
                "subnormal_epo": false
              }
            ],
            "path": "/api/calc/who_pv"
          },
          "type": "json"
        }
      },
      "schema": {
        "$schema": "https://json-schema.org/draft/2020-12/schema",
        "properties": {
          "input": {
            "additionalProperties": false,
            "properties": {
              "body": {
                "additionalProperties": false,
                "properties": {
                  "items": {
                    "items": {
                      "properties": {
                        "bone_marrow_panmyelosis": {
                          "description": "WHO 2016 marrow major as assigned by the caller (age-adjusted hypercellularity with panmyelosis, including pleomorphic mature megakaryocytes). true or false. magent does not read slides.",
                          "type": "boolean"
                        },
                        "hematocrit_percent": {
                          "description": "Hematocrit percent (10-70). Major 1 meets when male >49 or female >48. Optional when hemoglobin_g_dl is sent or increased_red_cell_mass is true. magent does not assay hematocrit.",
                          "type": "number"
                        },
                        "hemoglobin_g_dl": {
                          "description": "Hemoglobin in g/dL (3-22). Major 1 meets when male >16.5 or female >16.0. Optional when hematocrit_percent is sent or increased_red_cell_mass is true. At least one of hemoglobin_g_dl, hematocrit_percent, or increased_red_cell_mass true is required. magent does not assay hemoglobin.",
                          "type": "number"
                        },
                        "increased_red_cell_mass": {
                          "description": "Increased red-cell mass as assigned by the caller (Arber 2016 WHO 2016 major 1 alternative to Hb/Hct). true or false. true meets major 1 even when Hb/Hct are omitted or below threshold. magent does not measure red-cell mass.",
                          "type": "boolean"
                        },
                        "jak2_v617f_or_exon12": {
                          "description": "JAK2 V617F or JAK2 exon 12 mutation as assigned by the caller (Arber 2016 WHO 2016 major 3). true or false. magent does not sequence JAK2.",
                          "type": "boolean"
                        },
                        "sex": {
                          "description": "female or male (Arber 2016 WHO 2016 PV hemoglobin/hematocrit thresholds). Required even when only increased_red_cell_mass is used. Assigned by the caller.",
                          "enum": [
                            "female",
                            "male"
                          ],
                          "type": "string"
                        },
                        "subnormal_epo": {
                          "description": "Subnormal serum erythropoietin as assigned by the caller (Arber 2016 WHO 2016 minor criterion). true or false. magent does not assay EPO.",
                          "type": "boolean"
                        }
                      },
                      "required": [
                        "sex",
                        "increased_red_cell_mass",
                        "bone_marrow_panmyelosis",
                        "jak2_v617f_or_exon12",
                        "subnormal_epo"
                      ],
                      "type": "object"
                    },
                    "maxItems": 25,
                    "minItems": 1,
                    "type": "array"
                  }
                },
                "required": [
                  "items"
                ],
                "type": "object"
              },
              "headers": {
                "additionalProperties": {
                  "type": "string"
                },
                "type": "object"
              },
              "method": {
                "const": "POST",
                "type": "string"
              },
              "type": {
                "const": "http",
                "type": "string"
              }
            },
            "required": [
              "type",
              "method"
            ],
            "type": "object"
          },
          "output": {
            "properties": {
              "example": {
                "type": "object"
              },
              "type": {
                "type": "string"
              }
            },
            "required": [
              "type"
            ],
            "type": "object"
          }
        },
        "required": [
          "input"
        ],
        "type": "object"
      }
    }
  },
  "tags": [
    "who-2016",
    "pv",
    "hematology",
    "jak2",
    "calculator",
    "bazaar"
  ],
  "sourceHost": "api.magentlab.com",
  "lastUpdated": "2026-10-12T14:56:03.575Z",
  "quality": {
    "calls30d": 5,
    "uniquePayers30d": 3,
    "lastCalledAt": "2026-10-12T14:56:03.445Z"
  },
  "metadata": {
    "serviceName": "magent",
    "extensions": {
      "bazaar": {
        "info": {
          "iconUrl": "https://api.magentlab.com/favicon.ico",
          "input": {
            "body": {
              "items": [
                {
                  "bone_marrow_panmyelosis": false,
                  "hematocrit_percent": 45,
                  "hemoglobin_g_dl": 15,
                  "increased_red_cell_mass": false,
                  "jak2_v617f_or_exon12": false,
                  "sex": "male",
                  "subnormal_epo": false
                },
                {
                  "bone_marrow_panmyelosis": false,
                  "hematocrit_percent": 45,
                  "hemoglobin_g_dl": 15,
                  "increased_red_cell_mass": false,
                  "jak2_v617f_or_exon12": false,
                  "sex": "male",
                  "subnormal_epo": false
                }
              ]
            },
            "method": "POST",
            "type": "http"
          },
          "output": {
            "example": {
              "count": 2,
              "items": [
                {
                  "bone_marrow_panmyelosis": false,
                  "citation": {
                    "authors": "Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW",
                    "doi": "10.1182/blood-2016-03-643544",
                    "id": "arber-2016",
                    "pmid": "27069254",
                    "source": "Blood. 2016;127(20):2391-2405",
                    "title": "The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia"
                  },
                  "criteria": [
                    {
                      "factor": "major_1",
                      "met": false
                    },
                    {
                      "factor": "major_2",
                      "met": false
                    },
                    {
                      "factor": "major_3",
                      "met": false
                    },
                    {
                      "factor": "minor",
                      "met": false
                    }
                  ],
                  "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
                  "formula": "who_pv",
                  "formula_expression": "pv_criteria_met iff (major_1 and major_2 and major_3) or (major_1 and major_2 and minor); major_1 iff increased_red_cell_mass or (male and (hemoglobin_g_dl > 16.5 or hematocrit_percent > 49)) or (female and (hemoglobin_g_dl > 16.0 or hematocrit_percent > 48)); major_2 bone_marrow_panmyelosis; major_3 jak2_v617f_or_exon12; minor subnormal_epo (Arber 2016 WHO 2016 PV). Not WHO 2022",
                  "hematocrit_percent": 45,
                  "hemoglobin_g_dl": 15,
                  "increased_red_cell_mass": false,
                  "jak2_v617f_or_exon12": false,
                  "major_1": false,
                  "major_2": false,
                  "major_3": false,
                  "minor": false,
                  "pv_criteria_met": false,
                  "sex": "male",
                  "subnormal_epo": false
                },
                {
                  "bone_marrow_panmyelosis": false,
                  "citation": {
                    "authors": "Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW",
                    "doi": "10.1182/blood-2016-03-643544",
                    "id": "arber-2016",
                    "pmid": "27069254",
                    "source": "Blood. 2016;127(20):2391-2405",
                    "title": "The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia"
                  },
                  "criteria": [
                    {
                      "factor": "major_1",
                      "met": false
                    },
                    {
                      "factor": "major_2",
                      "met": false
                    },
                    {
                      "factor": "major_3",
                      "met": false
                    },
                    {
                      "factor": "minor",
                      "met": false
                    }
                  ],
                  "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
                  "formula": "who_pv",
                  "formula_expression": "pv_criteria_met iff (major_1 and major_2 and major_3) or (major_1 and major_2 and minor); major_1 iff increased_red_cell_mass or (male and (hemoglobin_g_dl > 16.5 or hematocrit_percent > 49)) or (female and (hemoglobin_g_dl > 16.0 or hematocrit_percent > 48)); major_2 bone_marrow_panmyelosis; major_3 jak2_v617f_or_exon12; minor subnormal_epo (Arber 2016 WHO 2016 PV). Not WHO 2022",
                  "hematocrit_percent": 45,
                  "hemoglobin_g_dl": 15,
                  "increased_red_cell_mass": false,
                  "jak2_v617f_or_exon12": false,
                  "major_1": false,
                  "major_2": false,
                  "major_3": false,
                  "minor": false,
                  "pv_criteria_met": false,
                  "sex": "male",
                  "subnormal_epo": false
                }
              ],
              "path": "/api/calc/who_pv"
            },
            "type": "json"
          }
        },
        "schema": {
          "$schema": "https://json-schema.org/draft/2020-12/schema",
          "properties": {
            "input": {
              "additionalProperties": false,
              "properties": {
                "body": {
                  "additionalProperties": false,
                  "properties": {
                    "items": {
                      "items": {
                        "properties": {
                          "bone_marrow_panmyelosis": {
                            "description": "WHO 2016 marrow major as assigned by the caller (age-adjusted hypercellularity with panmyelosis, including pleomorphic mature megakaryocytes). true or false. magent does not read slides.",
                            "type": "boolean"
                          },
                          "hematocrit_percent": {
                            "description": "Hematocrit percent (10-70). Major 1 meets when male >49 or female >48. Optional when hemoglobin_g_dl is sent or increased_red_cell_mass is true. magent does not assay hematocrit.",
                            "type": "number"
                          },
                          "hemoglobin_g_dl": {
                            "description": "Hemoglobin in g/dL (3-22). Major 1 meets when male >16.5 or female >16.0. Optional when hematocrit_percent is sent or increased_red_cell_mass is true. At least one of hemoglobin_g_dl, hematocrit_percent, or increased_red_cell_mass true is required. magent does not assay hemoglobin.",
                            "type": "number"
                          },
                          "increased_red_cell_mass": {
                            "description": "Increased red-cell mass as assigned by the caller (Arber 2016 WHO 2016 major 1 alternative to Hb/Hct). true or false. true meets major 1 even when Hb/Hct are omitted or below threshold. magent does not measure red-cell mass.",
                            "type": "boolean"
                          },
                          "jak2_v617f_or_exon12": {
                            "description": "JAK2 V617F or JAK2 exon 12 mutation as assigned by the caller (Arber 2016 WHO 2016 major 3). true or false. magent does not sequence JAK2.",
                            "type": "boolean"
                          },
                          "sex": {
                            "description": "female or male (Arber 2016 WHO 2016 PV hemoglobin/hematocrit thresholds). Required even when only increased_red_cell_mass is used. Assigned by the caller.",
                            "enum": [
                              "female",
                              "male"
                            ],
                            "type": "string"
                          },
                          "subnormal_epo": {
                            "description": "Subnormal serum erythropoietin as assigned by the caller (Arber 2016 WHO 2016 minor criterion). true or false. magent does not assay EPO.",
                            "type": "boolean"
                          }
                        },
                        "required": [
                          "sex",
                          "increased_red_cell_mass",
                          "bone_marrow_panmyelosis",
                          "jak2_v617f_or_exon12",
                          "subnormal_epo"
                        ],
                        "type": "object"
                      },
                      "maxItems": 25,
                      "minItems": 1,
                      "type": "array"
                    }
                  },
                  "required": [
                    "items"
                  ],
                  "type": "object"
                },
                "headers": {
                  "additionalProperties": {
                    "type": "string"
                  },
                  "type": "object"
                },
                "method": {
                  "const": "POST",
                  "type": "string"
                },
                "type": {
                  "const": "http",
                  "type": "string"
                }
              },
              "required": [
                "type",
                "method"
              ],
              "type": "object"
            },
            "output": {
              "properties": {
                "example": {
                  "type": "object"
                },
                "type": {
                  "type": "string"
                }
              },
              "required": [
                "type"
              ],
              "type": "object"
            }
          },
          "required": [
            "input"
          ],
          "type": "object"
        }
      }
    }
  },
  "liveness": {
    "reliability": null
  },
  "verified": false,
  "featured": false,
  "provider": {
    "host": "api.magentlab.com",
    "manifest_name": "api.magentlab.com",
    "source": "cdp-mirror",
    "source_manifest_url": "https://api.cdp.coinbase.com/platform/v2/x402/discovery/resources",
    "submitted_at": "2026-10-14T01:15:01.050Z"
  },
  "exampleResponse": {
    "example": {},
    "type": "string"
  }
}